
1. j transplant. 2016 may;16(5):1474-9. doi: 10.1111/ajt.13518. epub 2015 nov 20.

efficacy safety sofosbuvir-based antiviral therapy treat hepatitis c
virus infection kidney transplantation.

kamar n(1)(2)(3), marion o(1), rostaing l(1)(2)(3), cointault o(1), ribes d(1),
lavayssière l(1), esposito l(1), del bello a(1), métivier s(4), barange k(4),
izopet j(2)(3)(5), alric l(3)(6)(7).

author information: 
(1)department nephrology organ transplantation, chu rangueil, toulouse,
france.
(2)inserm u1043, ifr-bmt, chu purpan, toulouse, france.
(3)université paul sabatier, toulouse, france.
(4)department hepatology gastroenterology, toulouse, france.
(5)laboratory virology, chu purpan, toulouse, france.
(6)mr 152 ird-toulouse 3 university, toulouse, france.
(7)internal medicine-digestive department, chu purpan, toulouse, france.

erratum in
    j transplant. 2016 aug;16(8):2499.

comment in
    j transplant. 2016 may;16(5):1345-7.

there approved therapy hepatitis c virus (hcv) infection kidney
transplantation, data regarding use new-generation direct antiviral
agents (daas) published far. aims pilot study to
assess efficacy safety interferon-free sofosbuvir-based regimen 
treat chronic hcv infection kidney transplant recipients. twenty-five kidney
transplant recipients chronic hcv infection given, 12 (n = 19) or
24 weeks (n = 6), sofosbuvir plus ribavirin (n = 3); sofosbuvir plus daclatasvir 
(n = 4); sofosbuvir plus simeprevir, (n = 1) without ribavirin (n = 6);
sofosbuvir plus ledipasvir, (n = 1) without ribavirin (n = 9); and
sofosbuvir plus pegylated-interferon plus ribavirin (n = 1). rapid virological 
response, defined undetectable viremia week 4 starting daa therapy,
was observed 22 25 patients (88%). end therapy, hcv rna was
undetectable patients. 4 12 weeks completing daa therapy, all
had sustained virological response. tolerance anti-hcv therapy was
excellent adverse event observed. significant decrease in
calcineurin inhibitor levels observed hcv clearance. new-generation
oral daas efficient safe treat hcv infection kidney
transplantation.

© copyright 2015 american society transplantation american society
of transplant surgeons.

doi: 10.1111/ajt.13518 
pmid: 26587971  [indexed medline]

